Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$555K Buy
16,499
+578
+4% +$19.4K ﹤0.01% 2592
2023
Q4
$530K Sell
15,921
-530
-3% -$17.1K ﹤0.01% 2700
2023
Q3
$516K Buy
16,451
+744
+5% +$23.4K ﹤0.01% 2673
2023
Q2
$498K Buy
15,707
+5,184
+49% +$168K ﹤0.01% 2780
2023
Q1
$348K Buy
10,523
+1,090
+12% +$35.7K ﹤0.01% 2935
2022
Q4
$303K Sell
9,433
-540
-5% -$18.4K ﹤0.01% 3032
2022
Q3
$356K Buy
9,973
+456
+5% +$18.9K ﹤0.01% 2998
2022
Q2
$391K Sell
9,517
-948
-9% -$46K ﹤0.01% 2999
2022
Q1
$605K Buy
10,465
+1,517
+17% +$83K ﹤0.01% 2859
2021
Q4
$525K Buy
8,948
+716
+9% +$43.5K ﹤0.01% 3781
2021
Q3
$499K Buy
8,232
+469
+6% +$27.5K ﹤0.01% 3796
2021
Q2
$467K Sell
7,763
-666
-8% -$33.4K ﹤0.01% 3886
2021
Q1
$397K Sell
8,429
-4,244
-33% -$175K ﹤0.01% 3899
2020
Q4
$476K Buy
12,673
+4,677
+58% +$154K ﹤0.01% 3827
2020
Q3
$261K Sell
7,996
-1,683
-17% -$71.3K ﹤0.01% 3721
2020
Q2
$438K Buy
9,679
+2,454
+34% +$125K ﹤0.01% 3396
2020
Q1
$330K Buy
7,225
+1,191
+20% +$53.9K ﹤0.01% 3368
2019
Q4
$261K Sell
6,034
-996
-14% -$40.6K ﹤0.01% 3879
2019
Q3
$254K Buy
7,030
+2,289
+48% +$96.5K ﹤0.01% 3770
2019
Q2
$223K Buy
+4,741
New +$200K ﹤0.01% 3808
2017
Q4
Sell
-8,096
Closed -$241K 3977
2017
Q3
$241K Buy
+8,096
New +$222K ﹤0.01% 3845
2016
Q3
Sell
-20,181
Closed -$432K 4081
2016
Q2
$432K Sell
20,181
-708,922
-97% -$22.3M ﹤0.01% 3510
2016
Q1
$25M Sell
729,103
-103,584
-12% -$2.74M 0.03% 627
2015
Q4
$22.9M Buy
832,687
+18,694
+2% +$511K 0.03% 711
2015
Q3
$24.3M Buy
813,993
+324,088
+66% +$10.6M 0.03% 637
2015
Q2
$20.6M Buy
489,905
+269,296
+122% +$12.7M 0.02% 818
2015
Q1
$11M Buy
+220,609
New +$10.7M 0.01% 1139

Other funds holding ATEX

Credit Suisse's ATEX Position: Q1 2024 in Review

Credit Suisse increased its Anterix (ATEX) stake by 3.6% in Q1 2024, buying an estimated $19.4K and bringing the position to 16,499 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #2592.

Credit Suisse first reported a position in ATEX in Q1 2015 and has held it in 27 quarters since. The position peaked at $25M in Q1 2016. 98 funds tracked by Wall St. Rank hold ATEX as of Q1 2024.

  • Credit Suisse held 16,499 shares of Anterix worth $555K as of Q1 2024.
  • Credit Suisse bought 578 Anterix shares in Q1 2024, an estimated $19.4K.
  • Anterix made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2592 holding.
  • Credit Suisse first reported a position in Anterix in Q1 2015 and has held it in 27 quarters since.
  • Credit Suisse's Anterix position peaked at $25M in Q1 2016.
  • 98 funds tracked by Wall St. Rank held Anterix as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.